InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Homcy Charles J, Director. Director active across 2 companies, notably BridgeBio Pharma, Inc.. In total, 11 disclosures have been recorded. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Charles J Homcy is a Director at BridgeBio Pharma, Inc. He participates in the governance of the company and in strategic decision-making. His experience in the pharmaceutical sector is an asset to the organization.